Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety, Tolerability, Pharmacokinetics and Pharmacodynamics”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06155487
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Oral Administration of AJH-2947 in Healthy Korean and/or Caucasian Adult Male Subjects

Who this might be right for
Healthy VolunteersChronic Pain Syndrome
JMackem Co., Ltd 76
Early research (Phase 1)Study completedNCT04242199
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+9 more
Incyte Corporation 182
Early research (Phase 1)Ended earlyNCT01514981
What this trial is testing

AMG 761 in Adults With Asthma

Who this might be right for
Asthma
Amgen 7
Early research (Phase 1)Study completedNCT06226064
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001 in Healthy Participants

Who this might be right for
Dementia, Frontotemporal
Vesper Biotechnologies ApS 78
Early research (Phase 1)Study completedNCT01396187
What this trial is testing

Safety and Tolerability of Ascending Intravenous Doses of PF-05231023 In Adult Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 50
Early research (Phase 1)Looking for participantsNCT07619287
What this trial is testing

An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Patients With Myeloid Malignancies

Who this might be right for
Myeloid Malignancy
BeOne Medicines 118
Testing effectiveness (Phase 2)Study completedNCT01704404
What this trial is testing

7 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease

Who this might be right for
COPD
Mylan Inc. 62
Early research (Phase 1)Study completedNCT07256288
What this trial is testing

A Phase Ia Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of EA5 in Healthy Adult Subjects

Who this might be right for
Healthy Volunteers
Shanghai Lanyi Therapeutics Co., Ltd. 28
Early research (Phase 1)Study completedNCT05769595
What this trial is testing

Single Dose Study of MK-2060 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Older Japanese Participants on Dialysis (MK-2060-012)

Who this might be right for
End-Stage Renal Disease (ESRD)End-Stage Kidney Disease (ESKD)Kidney Failure, Chronic
Merck Sharp & Dohme LLC 17
Early research (Phase 1)Study completedNCT02618967
What this trial is testing

Single Ascending Dose Study of AMG 570 in Healthy Subjects

Who this might be right for
Systemic Lupus Erythematosus
Amgen 56
Testing effectiveness (Phase 2)Looking for participantsNCT07179575
What this trial is testing

Study of LW231 in Participants With Chronic Hepatitis B

Who this might be right for
Chronic HBV Infection
Shanghai Longwood Biopharmaceuticals Co., Ltd. 270
Testing effectiveness (Phase 2)Looking for participantsNCT06998407
What this trial is testing

ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors

Who this might be right for
HR+/HER2- Breast CancerHR+, HER2-, Advanced Breast Cancer
Avenzo Therapeutics, Inc. 380
Testing effectiveness (Phase 2)Ended earlyNCT03176277
What this trial is testing

ONO-7475 in Patients With Acute Leukemias

Who this might be right for
Acute LeukemiaMyelodysplastic Syndromes
Ono Pharmaceutical Co., Ltd. 42
Testing effectiveness (Phase 2)Looking for participantsNCT06632600
What this trial is testing

Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.

Who this might be right for
Chagas Disease
Novartis Pharmaceuticals 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT06280209
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMN 351 in Participants With Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
BioMarin Pharmaceutical 18
Early research (Phase 1)Not Yet RecruitingNCT07732309
What this trial is testing

ATG-201 in Adult Participants With Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusSystemic Sclerosis (SSc)Sjogren's Disease+1 more
Antengene Biologics Limited 149
Early research (Phase 1)Study completedNCT02390141
What this trial is testing

Multiple Ascending Doses of ZP4207 Administered to HV to Evaluate the Safety, Tolerability, PKs and PDs of ZP4207

Who this might be right for
Hypoglycemia
Zealand Pharma 24
Early research (Phase 1)UnknownNCT04801095
What this trial is testing

A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorColorectal Cancer+4 more
Wellmarker Bio 100
Early research (Phase 1)Study completedNCT05077501
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of ACD856

Who this might be right for
Alzheimer DiseaseCognition Disorder
AlzeCure Pharma 24
Early research (Phase 1)Ended earlyNCT04642365
What this trial is testing

Evaluate the Safety and Tolerability of RO7296682 in Combination With Atezolizumab in Participants With Advanced Solid Tumors.

Who this might be right for
Solid Tumors
Hoffmann-La Roche 49
Next Page